Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 7, Pages 1776
Publisher
MDPI AG
Online
2019-04-10
DOI
10.3390/ijms20071776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling
- (2019) Wanhu Fan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer
- (2018) Yu Song et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway
- (2018) Liyin Li et al. CELL BIOLOGY INTERNATIONAL
- Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis
- (2018) Pengbo Guo et al. EXPERIMENTAL CELL RESEARCH
- TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
- (2018) Ken-ichi Takayama et al. ONCOGENE
- TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2
- (2018) Zhanyao Tan et al. ONCOGENE
- Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
- (2018) Chao Yu et al. Theranostics
- Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells
- (2018) Ksenia S. Anufrieva et al. Genome Medicine
- TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway
- (2018) Ting-Ting Zhao et al. Journal of Cancer
- Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer
- (2018) Lorenzo Stramucci et al. Cancers
- An ATM/TRIM37/NEMO axis counteracts genotoxicity by activating nuclear-to-cytoplasmic NF-κB signaling
- (2018) Geyan Wu et al. CANCER RESEARCH
- TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1
- (2018) Loïc Lionnard et al. CELL DEATH AND DIFFERENTIATION
- TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway
- (2018) Yunxiao Liu et al. MOLECULAR CARCINOGENESIS
- Increased expression of tripartite motif (TRIM) like 2 promotes tumoral growth in human oral cancer
- (2018) Fumihiko Hayashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis
- (2018) Linmei Wang et al. CANCER BIOLOGY & THERAPY
- TRIM11 cooperates with HSF1 to suppress the anti-tumor effect of proteotoxic stress drugs
- (2018) Liang Chen et al. CELL CYCLE
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- TRIM32 overexpression improves chemoresistance through regulation of mitochondrial function in non-small-cell lung cancers
- (2018) Yaming Du et al. OncoTargets and Therapy
- Aberrant RNA Splicing in Cancer and Drug Resistance
- (2018) Bi-Dar Wang et al. Cancers
- Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
- (2017) Giovanni Luca Beretta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
- (2017) Robert Cornelison et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
- (2017) Francesca Mastropasqua et al. Molecular Cancer
- Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity
- (2017) Aman Sharma Nanomedicine
- miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer
- (2017) Xijun Wang et al. ONCOLOGY REPORTS
- Curcumin: A potentially powerful tool to reverse cisplatin-induced toxicity
- (2017) Ramin Rezaee et al. PHARMACOLOGICAL RESEARCH
- TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis
- (2017) Shigetsugu Hatakeyama TRENDS IN BIOCHEMICAL SCIENCES
- Expression of tripartite motif-containing protein 28 in primary breast carcinoma predicts metastasis and is involved in the stemness, chemoresistance, and tumor growth
- (2017) Surekha Damineni et al. TUMOR BIOLOGY
- miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
- (2017) Yao Liu et al. OncoTargets and Therapy
- Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
- (2017) Yi‑Jiong Li et al. Experimental and Therapeutic Medicine
- Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer
- (2017) Shenghua Tian et al. Oncology Letters
- TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
- (2017) Deguan Lv et al. Nature Communications
- Tumor Evolution as a Therapeutic Target
- (2017) Nabil Amirouchene-Angelozzi et al. Cancer Discovery
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role
- (2017) Mariano Caratozzolo et al. Genes
- Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
- (2017) T Avril et al. Oncogenesis
- TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells
- (2016) Jeffrey Q. Nguyen et al. CANCER BIOLOGY & THERAPY
- Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth
- (2016) Huai-Peng Lin et al. CANCER RESEARCH
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- TRIMming p53’s anticancer activity
- (2016) S Elabd et al. ONCOGENE
- Chemical probes and inhibitors of bromodomains outside the BET family
- (2016) Moses Moustakim et al. MedChemComm
- Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53
- (2016) Shan Xu et al. Oncology Letters
- DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
- (2016) M. R. Salehan et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
- (2015) Brian A. Boone et al. ANNALS OF SURGICAL ONCOLOGY
- TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survival
- (2015) Lucia Micale et al. BMC CANCER
- ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase
- (2015) Huibin Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Therapy-induced tumour secretomes promote resistance and tumour progression
- (2015) Anna C. Obenauf et al. NATURE
- TRIM25 has a dual function in the p53/Mdm2 circuit
- (2015) P Zhang et al. ONCOGENE
- Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development
- (2015) Mei-Yu Piao et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers
- (2015) Qianshan Ding et al. TUMOR BIOLOGY
- TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance
- (2015) Zhi-Feng Miao et al. VIRCHOWS ARCHIV
- TRIM66 overexpresssion contributes to osteosarcoma carcinogenesis and indicates poor survival outcome
- (2015) Yu Chen et al. Oncotarget
- TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma
- (2015) Mariano Francesco Caratozzolo et al. Oncotarget
- Combined MTOR and autophagy inhibition
- (2014) Reshma Rangwala et al. Autophagy
- The Four Faces of Autophagy: Implications for Cancer Therapy
- (2014) D. A. Gewirtz CANCER RESEARCH
- E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis
- (2014) Ju Liu et al. CELL DEATH AND DIFFERENTIATION
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- TRIM59 Is Up-regulated in Gastric Tumors, Promoting Ubiquitination and Degradation of p53
- (2014) Zhicheng Zhou et al. GASTROENTEROLOGY
- TRIM24 Is a p53-Induced E3-Ubiquitin Ligase That Undergoes ATM-Mediated Phosphorylation and Autodegradation during DNA Damage
- (2014) A. K. Jain et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification of TRIML2, a Novel p53 Target, that Enhances p53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes
- (2014) Che-Pei Kung et al. MOLECULAR CANCER RESEARCH
- Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
- (2014) B. Ashok Reddy et al. MOLECULAR CELL
- TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
- (2014) L-H Zhang et al. ONCOGENE
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake
- (2014) Angela Oliveira Pisco et al. Frontiers in Oncology
- TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity
- (2013) Moshe E. Gatt et al. BRITISH JOURNAL OF HAEMATOLOGY
- TRIM3, a tumor suppressor linked to regulation of p21Waf1/Cip1
- (2013) Y Liu et al. ONCOGENE
- O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
- (2013) C-H Fan et al. Cell Death & Disease
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
- (2013) P. Godwin et al. Frontiers in Oncology
- Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
- (2012) Min Shen et al. Anti-Cancer Agents in Medicinal Chemistry
- Phytochemicals As Chemosensitizers: From Molecular Mechanism to Clinical Significance
- (2012) Balachandran S. Vinod et al. ANTIOXIDANTS & REDOX SIGNALING
- Cellular senescence and cancer chemotherapy resistance
- (2012) Ryan R. Gordon et al. DRUG RESISTANCE UPDATES
- TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21
- (2012) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ubiquitylation of p53 by the APC/C inhibitor Trim39
- (2012) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TRIM29 negatively regulates p53 via inhibition of Tip60
- (2011) Takuya Sho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Mechanism of Cell Adaptation
- (2011) Valentina Fodale et al. CANCER JOURNAL
- TRIM40 promotes neddylation of IKK and is downregulated in gastrointestinal cancers
- (2011) K. Noguchi et al. CARCINOGENESIS
- Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2
- (2011) Hae Mi Joo et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Tripartite motif 8 (TRIM8) modulates TNF - and IL-1 -triggered NF- B activation by targeting TAK1 for K63-linked polyubiquitination
- (2011) Q. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
- (2010) E. Kupperman et al. CANCER RESEARCH
- TRIM8 modulates STAT3 activity through negative regulation of PIAS3
- (2010) F. Okumura et al. JOURNAL OF CELL SCIENCE
- Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells
- (2010) Manush Saydmohammed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Reactivation of p53: from peptides to small molecules
- (2010) Christopher J. Brown et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Mechanisms of tumor resistance to EGFR-targeted therapies
- (2009) Elizabeth A Hopper-Borge et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Discovery of new pyridoacridine alkaloids from Lissoclinum cf. badium that inhibit the ubiquitin ligase activity of Hdm2 and stabilize p53
- (2008) Jason A. Clement et al. BIOORGANIC & MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More